Merck and Eisai say two lung-cancer trials failed to meet their main goals

Two late-stage trials of a treatment for a certain type of non-small lung cancer failed to meet their primary goals, the companies said Friday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.